Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX/COVID-12 “Patria” recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico

• DOI: 10.1016/j.vaccine.2024.126511
• Publication Date: 2024-11-10T03:55:16Z
• Authors: Constantino López...; Martha Torres; Brenda Armenta-Copca; Niels H. Wacher; Laura Castro-Cast...; Andrea Alicia Col...; Tania Rivera-Hern...; Alejandro Torres-...; Matilde Damián-He...; Luis Ramírez-Mart...; Georgina Paz-De l...; Oscar Rojas-Martínez; Alejandro Suárez-...; Gustavo Peralta-S...; Claudia Carranza; Esmeralda Juárez; Horacio Zamudio-Meza; Laura E. Carreto-...; Mercedes Viettri; Damaris Romero-Ro...; Andrea Palencia; Edgar Reyna-Rosas; José E. Márquez-G...; David Sarfati-Miz...; Weina Sun; Héctor Elías Chag...; Felipa Castro-Per...; Peter Palese; Florian Krammer; Adolfo García-Sastre; Bernardo Lozano-D...